Navigation Links
GlycoVaxyn AG secures CHF 5.1 million Strategic Translation Award from the Wellcome Trust to finance clinical development of Shigella vaccine
Date:7/29/2013

under the age of five living in low income countries," said Richard Seabrook, Ph.D., head of Business Development at the Wellcome Trust. "With rising antibiotic resistance limiting our treatment options, we urgently need an affordable vaccine that will provide broad protection against the many strains of Shigella bacteria that cause disease."

Dr Michael Wacker, chief scientific officer of GlycoVaxyn added, "We are very honored to work with this prestigious global charitable foundation and proud to contribute to the development of a vaccine that addresses a critical medical need among millions around the world. GlycoVaxyn has previously conducted a Phase 1 study in healthy volunteers on a single serotype Shigella conjugate vaccine. This collaboration will enable us to investigate a new vaccine against a different single serotype, moving this important program forward towards a broad acting vaccine that protects against multiple serotypes."

Gordon Dougan, Ph.D., member of GlycoVaxyn's Scientific Advisory Board and professor at the Wellcome Trust Sanger Institute in Cambridge commented, "GlycoVaxyn is using highly innovative technology to break open new fields in vaccinology. I am delighted to see them work together with the Wellcome Trust to apply this technology to vaccines for children suffering from dysentery."

About GlycoVaxyn AGGlycoVaxyn is a privately-funded company developing a portfolio of novel bio-conjugate vaccines against common severe bacterial infections produced with its unique, proprietary in vivo glycosylation platform. With this platform, the company can develop and produce immunogenic glycoprotein conjugates in a biological process that circumvents many of the challenges and uncertainties involved in currently used chemical methods. Besides Shigella, the portfolio includes preclinical programs targeting major infectious
'/>"/>

SOURCE GlycoVaxyn AG
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. GlycoVaxyn AG announces Addition of Gerd Zettlmeissl, as Chairman of the Board of Directors
2. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
3. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
4. Roka Bioscience Secures $47.5 Million in Series D Financing
5. Generex Secures Commitments for $3.6M Capital Raise
6. PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
7. Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital
8. Bacterin Secures $25 Million Financing with OrbiMed
9. OncoSec Secures License for Electroporation Intellectual Property from University of South Florida
10. Aviir Diagnostic Laboratories Secures $8 Million In Funding From Silicon Valley Bank
11. Syngenta Secures EU Approval For Next Generation Fungicide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... 2014 Each year in the ... medical attention. In the military, burn injury is ... battlefield medical care. More than 800 service members ... wounds heal slowly, remain inflamed and often become ... debilitating and functionally damaging. While developments in supportive ...
(Date:9/29/2014)... start of the military conflicts in Iraq and Afghanistan, ... States with traumatic brain injury caused by exposure to ... explosive devices, or IEDs. Symptoms of traumatic brain injury ... and nausea, to more severe impairments in memory and ... Defense has recognized the critical importance and complexity of ...
(Date:9/29/2014)... Research and Markets  has announced the ... & Services, End-User , Application - Global Forecast to ... The global oligonucleotide synthesis market is expected to reach ... growing at a CAGR of 9.8% from 2014 to ... the basis of products and services, applications, end users, ...
(Date:9/29/2014)... diseases and biodiversity loss requires evolutionary thinking, argues ... Express that was co-authored by Bruce Tabashnik ... and Life Sciences. , For the first time, ... progress in addressing a broad set of challenges ... that consider evolutionary histories and the likelihood of ...
Breaking Biology Technology:Faster Healing with Fewer Scars 2Modeling shockwaves through the brain 2Modeling shockwaves through the brain 3Modeling shockwaves through the brain 4Oligonucleotide Synthesis (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) Market - Global Forecast to 2019 2Oligonucleotide Synthesis (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) Market - Global Forecast to 2019 3Evolutionary biology: It's not just for textbooks anymore 2Evolutionary biology: It's not just for textbooks anymore 3
... Iceland, Jan. 4 deCODE genetics,(Nasdaq: DCGN ) ... of deCODE,CEO Kari Stefansson,s presentation at the JPMorgan 26th ... 11:30 am PST / 7:30 pm GMT on,Thursday, January ... webcast can be accessed through the Investors page on ...
... to study technology to reduce greenhouse gas emissions, ... Midland,Company (NYSE: ADM ), the Midwest Geological ... (ISGS) announce that they are,working together on a ... and storage of carbon dioxide from ADM,s ethanol ...
... development programs, including review of positive results from the Phase ... ... Jan. 4 QuatRx Pharmaceuticals Company,today announced that the company chief ... 26th Annual JP Morgan Healthcare,Conference on Tuesday, January 8th, 2008, at ...
Cached Biology Technology:ADM, MGSC and ISGS Announce Carbon Sequestration Project 2ADM, MGSC and ISGS Announce Carbon Sequestration Project 3QuatRx Pharmaceuticals to Present at 26th Annual JP Morgan Healthcare Conference 2
(Date:9/29/2014)... Genome Institute (DOE JGI), a DOE Office of ... projects have been selected for the 2015 Community ... Caribbean waters, and from plant root micro-ecosystems, to ... watersheds, the CSP 2015 projects portfolio highlights diverse ... , "These projects catalyze JGI,s strategic shift ...
(Date:9/29/2014)... The BRAF inhibitor dabrafenib has significant anti-tumour activity ... cell lung cancer whose disease has progressed after ... the ESMO 2014 Congress in Madrid, Spain. ... BRAF have generated considerable interest because these mutations ... tyrosine-kinase inhibiting agents," says lead author Dr David ...
(Date:9/29/2014)... Oktoberfest is here, and that means ... for a cold one, taking that first ... chemicals have reacted to form compounds that ... Reactions explains why beers get skunky, and ... brews from going bad. Learn all about ...
Breaking Biology News(10 mins):2015 DOE JGI's science portfolio delves deeper into the Earth's data mine 22015 DOE JGI's science portfolio delves deeper into the Earth's data mine 32015 DOE JGI's science portfolio delves deeper into the Earth's data mine 42015 DOE JGI's science portfolio delves deeper into the Earth's data mine 52015 DOE JGI's science portfolio delves deeper into the Earth's data mine 62015 DOE JGI's science portfolio delves deeper into the Earth's data mine 72015 DOE JGI's science portfolio delves deeper into the Earth's data mine 82015 DOE JGI's science portfolio delves deeper into the Earth's data mine 9Promising results shown with targeted approaches in subsets of non-small cell lung cancer 2Promising results shown with targeted approaches in subsets of non-small cell lung cancer 3
... along the Mississippi River and other areas are altering ... a researcher from Iowa State University. Fred Janzen, ... studied turtle nesting habits and also accumulated research going ... the turtles to find out when they make nests ...
... snakes may slither in saltwater, but they sip the ... zoologist in a paper appearing this month in the ... Physiological and Biochemical Zoology . Harvey Lillywhite ... roughly 60 species of venomous sea snakes worldwide satisfy ...
... incoming administration will confront an array of threats and ... American president, says Steve Fetter, dean of the University ... won, Fetter asked six experts on his faculty with ... recommending steps to address key challenges. Most ...
Cached Biology News:Turtles alter nesting dates due to temperature change says ISU researcher 2Zoologists: Sea snakes seek out freshwater to slake thirst 2Zoologists: Sea snakes seek out freshwater to slake thirst 3Advice to the new administration: UM foreign and domestic policy guide 2Advice to the new administration: UM foreign and domestic policy guide 3Advice to the new administration: UM foreign and domestic policy guide 4Advice to the new administration: UM foreign and domestic policy guide 5Advice to the new administration: UM foreign and domestic policy guide 6Advice to the new administration: UM foreign and domestic policy guide 7
...
Contains L-glutamine....
... Resolution - Efficiently separates ... to 1000 bp. It ... PCR fragments, small DNA ... enzyme digestion, and double-stranded ...
...
Biology Products: